De novo hepatitis B infection after liver transplantation: Source of disease, incidence and impact

Liver Transplantation and Surgery

Volumn 4, Issue 2, 1998, Pages 119-127

  Fabia, R ^a   Levy, M F ^a   Crippin, J ^a   Tillery, W ^a   Netto, G J ^a   Aguanno, J ^a   Dysert, P ^a   Goldstein, R M ^a   Husberg, B S ^a   Gonwa, T A ^a   Klintmalm, G B ^a   Pruett, T L ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE SEVERITY; FEMALE; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; VACCINATION; VIRUS HEPATITIS;

EID: 0031907752     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040210     Document Type: Article

References (0)